Alpha₂-adrenergic and VIP receptors in rabbit ciliary processes interact

References

• Gregory D. S., Bausher L. P., Bromberg B. B., Sears M. L. The beta‐adrenergic receptor and adenyl cyclase of rabbit ciliary processes. New Directions in Ophthalmic Research, M. L. Sears. Yale University Press, New Haven, CT 1981; 127–145
   Google Scholar
• Sears M. L. Regulation of aqueous flow by the adenylate cyclase receptor complex in the ciliary epithelium. Am. J. Ophthalmol. 1985; 100: 194–198
   PubMed Web of Science ®Google Scholar
• Sears M. L., Caprioli J., Kondo K., Bausher L. A mechanism for the control of aqueous humor formation. Glaucoma: Applied Pharmacology in Medical Treatment, S. M. Drance, A. H. Neufeld. Grune & Stratton, Inc., Orlando, FL 1984; 303–324
   Google Scholar
• Neufeld A. H. The mechanism of action of adrenergic drugs in the eye. Glaucoma: Applied Pharmacology in Medical Treatment, S. M. Drance, A. H. Neufeld. Grune & Stratton, Inc., Orlando, FL 1984; 277–301
   Google Scholar
• Potter D. E. Adrenergic pharmacology of aqueous humor dynamics. Pharmacol. Rev. 1981; 33: 133–153
   PubMed Web of Science ®Google Scholar
• Nathanson J. A. Adrenergic regulation of cerebrospinal fluid and aqueous humor. Trends in Pharmacol. Sci. 1982; 3: 452–454
   Web of Science ®Google Scholar
• Neufeld A. H., Page E. D. In vitro determination of the ability of drugs to bind to adrenergic receptors. Invest. Ophthalmol. Vis. Sci. 1977; 16: 1118–1124
   PubMed Web of Science ®Google Scholar
• Mittag T. W., Tormay A. Adrenergic receptor subtypes in rabbit iris‐ciliary body membranes: classification by radioligand studies. Exp. Eye Res. 1985; 40: 239–249
   PubMed Web of Science ®Google Scholar
• Mittag T. W., Tormay A. Drug responses of adenylate cyclase in iris‐ciliary body determined by adenine labelling. Invest, Ophthalmol. Vis. Sci. 1985; 26: 396–399
   PubMed Web of Science ®Google Scholar
• Bausher L. P., Gregory D. S., Sears M. L. Interaction between alpha‐and beta2‐adrenergic receptors in rabbit ciliary processes. Current Eye Res. 1987; 6: 497–505
   PubMed Web of Science ®Google Scholar
• Neufeld A. H., Page E. D. Regulation of adrenergic neuromuscular transmission in the rabbit iris. Exp. Eye Res. 1975; 20: 549–561
   PubMed Web of Science ®Google Scholar
• Jumblatt J. E., Liu J. G.H., North G. T. Alpha2‐adrenergic modulation of nor‐epinephrine secretion in the perfused rabbit iris‐ciliary body. Current Eye Res. 1987; 6: 767–777
   PubMed Web of Science ®Google Scholar
• Mittag T. W., Tormay A., Podos S. M. Vasoactive intestinal peptide and intraocular pressure: adenylate cyclase activation and binding sites for vasoactive intestinal peptide in membranes of ocular ciliary processes. J. Pharmacol. Exp. Therap. 1987; 241: 230–235
   PubMed Web of Science ®Google Scholar
• Bausher L. P., Gregory D. S., Sears M. L. Interaction between VIP and alpha2‐adrenergic receptors in rabbit ciliary processes. Invest. Ophthalmol. Vis. Sci. (Suppl.) 1987; 28: 11
   Google Scholar
• DeVries G. W., Dowling M., Potter D. The effect of epinephrine on β‐adrenergic and VIP stimulated cyclic AMP in rabbit ciliary body. Invest. Ophthalmol. Vis. Sci. (Suppl.) 1988; 29: 201
   Web of Science ®Google Scholar
• Bylund D. B., U'Prichard D. C. Characterization of alpha1‐and alpha2‐adrenergic receptors. Int. Rev. Neurobiol. 1983; 24: 343–431
   PubMed Web of Science ®Google Scholar
• Gregory D., Sears M., Bausher L., Mishima H., Mead A. Intraocular pressure and aqueous flow are decreased by cholera toxin. Invest. Ophthalmol. Vis. Sci. 1981; 20: 371–381
   PubMed Web of Science ®Google Scholar
• Uddman R., Alumets J., Ehinger B., Hakanson R., Loren I., Sundler F. Vasoactive intestinal peptide nerves in ocular and orbital structures of the cat. Invest. Ophthalmol. Vis. Sci. 1980; 19: 878–885
   PubMed Web of Science ®Google Scholar
• Mishima S. Ocular effects of beta‐adrenergic agents. Survey of Ophthalmol. 1982; 27: 187–208
   PubMed Web of Science ®Google Scholar
• Jumblatt J. E., North G. T. Potentiation of sympathetic neurosecretion by forskolin and cyclic AMP in the rabbit irisciliary body. Current Eye Res. 1986; 5: 495–502
   PubMed Web of Science ®Google Scholar
• Burke J. A., Potter D. E. Ocular effects of a relatively selective α‐2 agonist (UK‐14, 304–18) in cats, rabbits and monkeys. Current Eye Res. 1986; 5: 665–676
   PubMed Web of Science ®Google Scholar
• Serle J., Mittag T., Steidl S., Saffra N., Severin C., Podos S. Effect of sympathectomy on alpha‐2 adrenergic and DA‐2 dopaminergic agonist IOP responses. Invest. Ophthalmol. Vis. Sci. (Suppl.) 1988; 29: 15
   Google Scholar
• Steidl S., Serle J., Wang R. ‐F., Podos S., Siddique A. Selective alpha adrenergic agents in cynomolgus monkeys. Invest. Ophthalmol. Vis. Sci. (Suppl.) 1988; 29: 15
   Google Scholar
• Lee D. A., Topper J. E., Brubaker R. F. Effect of clonidine on aqueous humor flow in normal human eyes. Exp. Eye Res. 1984; 38: 239–246
   PubMed Web of Science ®Google Scholar
• Gharagozloo N. Z., Relf S. J., Brubaker R. F. Aqueous flow is reduced by the alpha‐adrenergic agonist, apraclonidine hydrochloride (ALO 2145). Ophthalmology 1988; 95: 1217–1220
   PubMed Web of Science ®Google Scholar
• Caprioli J., Sears M. Forskolin lowers intraocular pressure in rabbits, monkeys, and man. The Lancet 1983; 1: 958
   PubMed Web of Science ®Google Scholar
• Caprioli J., Sears M., Bausher L., Gregory D., Mead A. Forskolin lowers intraocular pressure by reducing aqueous flow. Invest. Ophthalmol. Vis. Sci. 1984; 25: 268–277
   PubMed Web of Science ®Google Scholar
• Burstein N. L., Sears M. L., Mead A. Aqueous flow in human eyes is reduced by forskolin, a potent adenylate cyclase activator. Exp. Eye Res. 1984; 39: 745–749
   PubMed Web of Science ®Google Scholar
• Bartels S. P., Lee S. R., Neufeld A. H. The effects of forskolin on cyclic AMP, intraocular pressure and aqueous humor formation in rabbits. Current Eye Res. 1987; 6: 307–320
   PubMed Web of Science ®Google Scholar
• Hoshi T., Garber S. S., Aldrich R. W. Effect of forskolin on voltage‐gated K+ channels is independent of adenylate cyclase activation. Science 1988; 240: 1652–1655
   PubMed Web of Science ®Google Scholar
• Wagoner P. K., Pallotta B. S. Modulation of acetylcholine receptor desensitization by forskolin is independent of cAMP. Science 1988; 240: 1655–1657
   PubMed Web of Science ®Google Scholar
• Aksamit R. R., Backlund P. S., Jr., Cantoni G. L. Cholera toxin inhibits chemotaxis by a cAMP‐independent mechanism. Proc. Natl. Acad. Sci. U.S.A. 1985; 82: 7475–7479
   PubMed Web of Science ®Google Scholar
• Imboden J. B., Shoback D. M., Pattison G., Stobo J. D. Cholera toxin inhibits T‐cell antigen receptor‐mediated increases in inositol trisphosphate and cytoplasmic free calcium. Proc. Natl. Acad. Sci. U.S.A. 1986; 83: 5673–5677
   PubMed Web of Science ®Google Scholar
• Isom L. L., Cragoe E. J., Jr., Limbird L. α2‐Adrenergic receptors accelerate Na+/H+ exchange in neuroblastoma X glioma cells. J. Biol. Chem. 1987; 262: 6750–6757
   PubMed Web of Science ®Google Scholar
• Isom L. L., Cragoe E. J., Jr., Limbird L. Multiple receptors linked to inhibition of adenylate cyclase accelerate Na+/H+ exchange in neuroblastoma X glioma cells via a mechanism other than decreased cAMP accumulation. J. Biol. Chem. 1987; 262: 17504–17509
   PubMed Web of Science ®Google Scholar
• Jumblatt J. E., North G. T., Hackmiller R. C. Muscarinic cholinergic inhibition of adenylate cyclase in rabbit ciliary processes. Invest. Ophthalmol. Vis. Sci. (Suppl.) 1988; 29: 324
   Google Scholar